Research Areas

(Design, Synthesis, Evaluation, Publication & Dispersion)

Our R&D division focuses on the design, synthesis, and evaluation of innovative small molecules aimed at addressing complex therapeutic challenges. From concept to laboratory validation, we employ cutting-edge techniques to explore molecular pathways and optimize lead compounds. Our work culminates in peer-reviewed publications and strategic dispersion to accelerate scientific progress and collaborative innovation. 

(ML-guided Functional Analog Designing

Instant evaluation through Computational Bio-Assays)

Our proprietary software leverages machine learning (ML) to design functional analogs of small molecules with precision and efficiency. Integrated with computational bio-assays, the platform enables instant evaluation of molecular properties, biological activity, and potential efficacy—streamlining the discovery pipeline and accelerating data-driven decision-making. 

(Preprocessed Data for QSAR Model development)

We offer preprocessed, publication-ready datasets specifically tailored for QSAR model development. Curated with precision, our datasets are cleaned, normalized, and enriched to support robust model training and reproducible research—accelerating your path from data to discovery. 

(Computational/ ML-AI guided  Research & Developments for human health care)

We provide online live and offline training sessions focused on computational and ML/AI-guided research and development in the field of human healthcare. Our programs are designed to bridge the gap between theory and application, empowering researchers, students, and professionals with the skills needed to drive innovation and translational outcomes in biomedical science. 

(Processing and Analysis of Transcriptome and Whole Exome Sequencing (WES/WXS) for personalised interpretation of diseases)

Our pharmacogenomics services focus on personalized disease interpretation through the processing and analysis of Transcriptome and Whole Exome Sequencing (WES/WXS) data. By integrating genetic insights with clinical relevance, we enable tailored therapeutic strategies that reflect each individual's unique molecular profile—advancing the future of precision medicine.